Will AbbVie file a lawsuit against UnitedHealth over Humira removal by end of 2024? | Binary | | | 3 months ago | |
Will UnitedHealth stock price increase by the end of Q1 2024? | Binary | | | 3 months ago | |
Will Johnson & Johnson stock price increase by at least 5% by the end of Q3 2024 following its dividend announcement? | Binary | | | 5 months ago | |
How will Johnson & Johnson's stock perform relative to its peers by the end of 2024? | Categorical | | | 5 months ago | |
What will be Johnson & Johnson's revenue in Q3 2024? | Categorical | | | 5 months ago | |
Will Johnson & Johnson meet its revised full-year EPS guidance for 2024? | Binary | | | 5 months ago | |
Will OptumRx biosimilars capture more than 10% market share by end of 2024? | Binary | | | 3 months ago | |
What will be the market share distribution among Humira, Amjevita, and Wezlana by end of 2024? | Categorical | | | 3 months ago | |
What will be the percentage decline in AbbVie's market share for Humira by end of 2024? | Categorical | | | 3 months ago | |
Which biosimilar will have the highest market share by end of 2024? | Categorical | | | 3 months ago | |
What will be Johnson & Johnson's EPS in Q3 2024? | Categorical | | | 5 months ago | |
Will Johnson & Johnson stock price be higher at the end of Q3 2024 compared to its price on July 17, 2024? | Binary | | | 5 months ago | |
